Factors Influencing Subclinical Atherosclerosis in Patients with Biopsy-Proven Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease, with a worldwide prevalence of approximately 25%.
Nonalcoholic fatty liver disease (NAFLD) is a major chronic liver disease, with a worldwide prevalence of approximately 25%.
Atherosclerosis (ATH) and ATH-related diseases represent the leading cause of disability and mortality in the Western world.
It is estimated that nearly 1.5 billion adults in the world will have hypertension in the decade ahead.
The European Society of Cardiology (ESC) guidelines on the management of ventricular arrhythmias and prevention on SCD published in 2015 considered the new insights of the natural history of diseases predisposing to SCD.
Chronic heart failure (CHF) has become a global epidemic in the 21st century with considerable effects on a patient’s quality of life and a tremendous burden to healthcare systems.